Atrophic gastritis patients take timely measures to treat the life expectancy is not significantly affected, generally can live 20 years, if the patient appears to be severe heterogeneous hyperplasia, cancer, not timely treatment, may affect the life expectancy.
Whether atrophic gastritis can live 20 years needs to be judged according to the patient’s condition and treatment, if the patient’s atrophic gastritis is not serious, timely and under the guidance of the doctor to follow the doctor’s instructions with bismuth pectin, magnesium alumina carbonate chewable tablets and other gastric mucosal protectants, or mosapride, domperidone and other gastric power enhancers. Most patients can effectively control their condition by taking appropriate measures for treatment under the guidance of their doctors, which usually has no impact on their lives, and most patients can live up to 20 years.
If patients with atrophic gastritis develop severe heterotrophic hyperplasia and do not take timely measures to treat the disease, the disease may develop into gastric cancer, which will affect the survival rate of patients, and the survival time of some patients may not reach 20 years.
It is recommended that patients with atrophic gastritis need to consult a doctor in a timely manner, who will determine whether they can live for 20 years according to the severity of the disease, and will also guide patients to choose the appropriate way of treatment.